Linezolid is an antibiotic (oxazolidinone class) used to treat infections caused by gram-positive bacteria, such as pneumonia, sepsis (bacterial infection in the bloodstream), skin and skin structure infections. It is one of the strongest antibiotics and especially prescribed for patients with Methicillin-Resistant Staphylococcus Aureus (MRSA). Also, Linezolid is used as essential 2nd-line Tuberculosis treatment as it is listed in the 2016 WHO guidelines for the core 2nd-line treatment of tuberculosis. It is specifically useful for the MDR/XDR-TB (Multi Drug Resistant / Extensive Drug Resistant) patients since Linezolid is effective for many patients who have resistance to other drugs. Hence, this product is highly required by countries burdened with the above-mentioned bacterial infections and tuberculosis.
Tenofovir+Lamivudine+Efavirenz (TLE) and Tenofovir+Lamivudine (TL) tripleand dualcombination tablets are more affordable and clinically equivalent versions of Atripla and Truvada, the mainstay of 1st-line HIV treatment antiretroviral medicines. In our products, lamivudine replaces the emtricitabine (in Atripla and Truvada) since lamivudine is considered as equivalent in terms of clinical effectiveness. The fact that TLE and TL cover the highest portions in international HIV procurement proves their effectiveness and price competitiveness.
Celltrion, Inc., a Korea-based global pharmaceutical company, recently established its state-of-the-art cGMP (US/EU) compliant manufacturing facility with a manufacturing capacity of up to 10 billion tablets annually. Now we proudly present our antibiotic / anti-tuberculosis and anti-HIV products as below. Based on our most stringent quality control and the most competitive price achieved by economy of scale, we will be the most trusted partner in meeting your needs.
Korean-Products.com | Blog Magazine of Korean products, brands and Goods